Survey of carboplatin dosing strategies in oncology practices-Reference-Cited by-同舟云学术

Survey of carboplatin dosing strategies in oncology practices

Published:2013-07 Issue:4 Volume:53 Page:420-422
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Blankenship Patrick,Aubrey Waddell J.

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference10 articles.

1. Verifying carboplatin doses in adult patients with the Calvert and modified Calvert formulas;Waddell;Hosp Pharm,2000

2. Carboplatin dosage: prospective evaluation of a simple formula based on renal function;Calvert;J Clin Oncol,1989

3. Carboplatin dosing accounting for the renal and hematologic status of patients;Busse;Clin J Oncol Nurs,2003

4. Food and Drug Administration. Carboplatin dosing. www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm228974.htm Accessed October 8, 2010.

5. Glomerular filtration rate (GFR) in patients with stage I testicular seminoma treated with adjuvant carboplatin: a comparison of six formulae compared to a radioisotope gold standard [abstract];Cathomas;J Clin Oncol,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault;Journal of Oncology Pharmacy Practice;2020-12-09

2. Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP);Breast Cancer Research and Treatment;2020-08-29

3. Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance;Cancer Chemotherapy and Pharmacology;2020-01-09

4. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review;Journal of Oncology Pharmacy Practice;2018-10-18

5. Arzneimitteltherapiesicherheit in der klinischen Onkologie;Forum;2015-11-14